Patents/Assignees

Sirnaomics, Inc.

5 patents in portfolio

US12612626utility2026
Sirna Compound That Inhibits Expression of APOC3
0 cites
US12600967utility2026
Sirna Compound That Inhibits Complement Factor B (CFB)
0 cites
US12378552utility2025
Oligomeric Compound for Inhibiting Expression of Factor XI
0 cites
US12054714utility2024
Peptide Docking Vehicle for Targeted Nucleic Acid Delivery
0 cites
US12006500utility2024
Composition and Methods of Rnai Prophylactics and Therapeutics for Treatment of Severe Acute Respiratory Infection Caused by 2019 Novel Coronavirus (2019-ncov)
0 cites